129 related articles for article (PubMed ID: 8529534)
1. Assessment of nalmefene glucuronide as a selective gut opioid antagonist.
Cheskin LJ; Chami TN; Johnson RE; Jaffe JH
Drug Alcohol Depend; 1995 Aug; 39(2):151-4. PubMed ID: 8529534
[TBL] [Abstract][Full Text] [Related]
2. [Nalmefene and Opioid Withdrawal Syndrome: Analysis of the Global Pharmacovigilance Database for Adverse Drug Reactions].
Dahmke H; Kupferschmidt H; Kullak-Ublick GA; Weiler S
Praxis (Bern 1994); 2015 Oct; 104(21):1129-34. PubMed ID: 26463904
[TBL] [Abstract][Full Text] [Related]
3. A review of the potential role of methylnaltrexone in opioid bowel dysfunction.
Foss JF
Am J Surg; 2001 Nov; 182(5A Suppl):19S-26S. PubMed ID: 11755893
[TBL] [Abstract][Full Text] [Related]
4. Severe opioid withdrawal syndrome after a single dose of nalmefene.
Donnerstag N; Schneider T; Lüthi A; Taegtmeyer A; Raetz Bravo A; Mehlig A
Eur J Clin Pharmacol; 2015 Aug; 71(8):1025-6. PubMed ID: 26050241
[No Abstract] [Full Text] [Related]
5. Opioid substitution therapy or hidden opioids are a minefield for nalmefene: an atypical case series of 11 patients in Lorraine.
Yéléhé-Okouma M; Martini H; Lemarié J; Labroca P; Petitpain N; Gibaja V; Paille F; Gillet P
Fundam Clin Pharmacol; 2017 Oct; 31(5):574-579. PubMed ID: 28322465
[TBL] [Abstract][Full Text] [Related]
6. Management of precipitated opiate withdrawal syndrome induced by nalmefene mistakenly prescribed in opiate-dependent patients: a review for clinicians.
Franchitto N; Jullian B; Salles J; Pelissier F; Rolland B
Expert Opin Drug Metab Toxicol; 2017 Jun; 13(6):669-677. PubMed ID: 28343423
[TBL] [Abstract][Full Text] [Related]
7. Evidence for the delivery of narcotic antagonists to the colon as their glucuronide conjugates.
Simpkins JW; Smulkowski M; Dixon R; Tuttle R
J Pharmacol Exp Ther; 1988 Jan; 244(1):195-205. PubMed ID: 3335997
[TBL] [Abstract][Full Text] [Related]
8. Naldemedine (Symproic) for opioid-induced constipation.
Med Lett Drugs Ther; 2017 Dec; 59(1535):196-198. PubMed ID: 29186083
[No Abstract] [Full Text] [Related]
9. Methylnaltrexone for reversal of constipation due to chronic methadone use: a randomized controlled trial.
Yuan CS; Foss JF; O'Connor M; Osinski J; Karrison T; Moss J; Roizen MF
JAMA; 2000 Jan; 283(3):367-72. PubMed ID: 10647800
[TBL] [Abstract][Full Text] [Related]
10. Unintentional rapid opioid detoxification: case report.
Singh SM; Sharma B
Psychiatr Danub; 2009 Mar; 21(1):65-7. PubMed ID: 19270623
[TBL] [Abstract][Full Text] [Related]
11. Opioids and opioid receptors in the enteric nervous system: from a problem in opioid analgesia to a possible new prokinetic therapy in humans.
Holzer P
Neurosci Lett; 2004 May; 361(1-3):192-5. PubMed ID: 15135926
[TBL] [Abstract][Full Text] [Related]
12. A double-blind, placebo-controlled study of oral nalmefene for alcohol dependence.
Mason BJ; Salvato FR; Williams LD; Ritvo EC; Cutler RB
Arch Gen Psychiatry; 1999 Aug; 56(8):719-24. PubMed ID: 10435606
[TBL] [Abstract][Full Text] [Related]
13. Opioid Withdrawal Precipitated by Long-Acting Antagonists.
Kunzler NM; Wightman RS; Nelson LS
J Emerg Med; 2020 Feb; 58(2):245-253. PubMed ID: 32005608
[TBL] [Abstract][Full Text] [Related]
14. Time course of naloxone-precipitated withdrawal after acute methadone exposure in humans.
Stitzer ML; Wright C; Bigelow GE; June HL; Felch LJ
Drug Alcohol Depend; 1991 Dec; 29(1):39-46. PubMed ID: 1665778
[TBL] [Abstract][Full Text] [Related]
15. Targeted nalmefene with simple medical management in the treatment of heavy drinkers: a randomized double-blind placebo-controlled multicenter study.
Karhuvaara S; Simojoki K; Virta A; Rosberg M; Löyttyniemi E; Nurminen T; Kallio A; Mäkelä R
Alcohol Clin Exp Res; 2007 Jul; 31(7):1179-87. PubMed ID: 17451401
[TBL] [Abstract][Full Text] [Related]
16. Double-blind, randomized study of nalmefene and naloxone in emergency department patients with suspected narcotic overdose.
Kaplan JL; Marx JA; Calabro JJ; Gin-Shaw SL; Spiller JD; Spivey WL; Gaddis GM; Zhao N; Harchelroad FP
Ann Emerg Med; 1999 Jul; 34(1):42-50. PubMed ID: 10381993
[TBL] [Abstract][Full Text] [Related]
17. Acute physical dependence in humans: repeated naloxone-precipitated withdrawal after a single dose of methadone.
Wright C; Bigelow GE; Stitzer ML; Liebson IA
Drug Alcohol Depend; 1991 Mar; 27(2):139-48. PubMed ID: 1647293
[TBL] [Abstract][Full Text] [Related]
18. Nalmefene: a long-acting opioid antagonist. Clinical applications in emergency medicine.
Wang DS; Sternbach G; Varon J
J Emerg Med; 1998; 16(3):471-5. PubMed ID: 9610980
[TBL] [Abstract][Full Text] [Related]
19. Opioid-dependent error processing.
Fellows-Smith J
J Opioid Manag; 2011; 7(6):443-9. PubMed ID: 22320026
[TBL] [Abstract][Full Text] [Related]
20. Clinical status of methylnaltrexone, a new agent to prevent and manage opioid-induced side effects.
Yuan CS
J Support Oncol; 2004; 2(2):111-7; discussion 119-22. PubMed ID: 15328815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
